Study of the aHUS Diagnosis Process- the “whys”, “whats” and “hows”
It is now over two years ago that Global Action began a major study of the aHUS Diagnosis Process, it is…
It is now over two years ago that Global Action began a major study of the aHUS Diagnosis Process, it is…
aHUS patients in clinical trials are monitored for adverse events and personal outcomes experience while on treatment. Adverse events have been…
Kamal Shah is a Director/Trustee of aHUS alliance Global Action. He first had aHUS over 25 years ago. It was triggered…
Hey Global aHUS alliance. Hi, but its aHUS alliance Global Action actually Whatever, let's settle on GA. Well we have been…
Early in November in the USA thoughts not just turn to elections but also to Kidney Week. The American Society of…
It has been known for decades that what is called " de novo " aHUS can happen to a kidney donor…
You don't have aHUS any more. Well you have aHUS but not for much longer. And no you won't be cured.…
To answer some of the questions in the aHUS Patients Research Agenda clinical trials will be needed. Take the issue of…
Earlier this year in the series of articles following the Rare Disease Day video one featured a question by Elisabeth from…